FDA panel backs new diabetes drug
An FDA advisory panel on Friday endorsed Bristol-Myers Squibb’s and Merck’s Pargluva, developed to control blood sugar levels and cholesterol ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.